| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.9B | $10.5B | $10.9B | $11.0B | $10.6B | $7.7B | $8.2B | $8.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $0.7B | $0.7B | $0.6B | $0.6B | $0.5B | $0.6B | $0.6B |
| Operating Income | $4.2B | $3.3B | $4.3B | $3.0B | $2.6B | $2.2B | $1.9B | $0.8B |
| Net Income | $2.6B | $2.2B | $3.2B | $2.0B | $1.5B | $0.2B | $0.8B | $-0.2B |
| EPS (Basic) | $2.14 | $1.82 | $2.61 | $1.68 | $1.25 | $0.17 | $0.70 | $-0.16 |
| EPS (Diluted) | $2.14 | $1.82 | $2.60 | $1.67 | $1.24 | $0.17 | $0.70 | $-0.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $58.6B | $54.5B | $52.6B | $48.4B | $47.6B | $44.2B | $46.0B | $45.3B |
| Current Assets | $3.2B | $2.7B | $4.5B | $3.8B | $4.5B | $1.4B | $1.6B | $1.5B |
| Cash & Equivalents | — | — | — | $0.2B | $1.7B | $0.1B | $0.3B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $6.1B | $5.3B | $5.8B | $4.9B | $5.0B | $2.3B | $4.0B | $1.8B |
| Stockholders' Equity | $12.8B | $12.4B | $12.4B | $11.5B | $11.4B | $11.8B | $13.4B | $14.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.9B | $5.0B | $5.9B | $4.9B | $3.9B | $3.5B | $3.7B | $3.3B |
| Investing Cash Flow | $-5.5B | $-4.9B | $-3.9B | $-3.4B | $-1.5B | $-1.6B | $-2.8B | $-2.7B |
| Capital Expenditures | $4.9B | $2.6B | $2.5B | $2.3B | $1.2B | $1.2B | $2.1B | $3.3B |
| Financing Cash Flow | $-0.4B | $-2.2B | $-0.0B | $-3.0B | $-0.9B | $-2.1B | $-0.7B | $-1.3B |